Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

$7.54Billion– No. of Holdings #333

ARMISTICE CAPITAL, LLC Performance:
2024 Q1: 4.09%YTD: 4.09%2023: -1.75%

Performance for 2024 Q1 is 4.09%, and YTD is 4.09%, and 2023 is -1.75%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.6 Billions. In it's latest 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $7.5 Billions as of 31 Mar, 2024.

The top stock holdings of ARMISTICE CAPITAL, LLC are PTCT, NBIX, INCY. The fund has invested 2.6% of it's portfolio in PTC THERAPEUTICS INC and 1.9% of portfolio in NEUROCRINE BIOSCIENCES INC.

The fund managers got completely rid off JAZZ PHARMACEUTICALS PLC (JAZZ), KRAFT HEINZ CO (KHC) and MIRATI THERAPEUTICS INC (MRTX) stocks. They significantly reduced their stock positions in COLGATE PALMOLIVE CO (CL), CONSTELLATION BRANDS INC (STZ) and AGRIFORCE GROWING SYSTEMS LT (AGRI). ARMISTICE CAPITAL, LLC opened new stock positions in CYTOKINETICS INC (CYTK), COCA COLA CO (KO) and GRIFOLS S A (GIKLY). The fund showed a lot of confidence in some stocks as they added substantially to STEAKHOLDER FOODS LTD (STKH), PENN ENTERTAINMENT INC (PENN) and TARGET CORP (TGT).
ARMISTICE CAPITAL, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of 4.09% in the last quarter. In trailing 12 months, it's portfolio return was 1.45%.

New Buys

Ticker$ Bought
cytokinetics inc106,966,000
coca cola co46,047,900
grifols s a44,408,600
humana inc43,403,800
sensient technologies corp26,223,000
campbell soup co24,463,700
exxon mobil corp22,004,200
cervomed inc17,110,700

New stocks bought by ARMISTICE CAPITAL, LLC

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
colgate palmolive co-99.21
constellation brands inc-98.78
agriforce growing systems lt-98.00
edible garden ag inc-96.67
american rebel holdings inc-96.00
bruush oral care inc-96.00
cingulate inc-95.00
locafy limited-95.00

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
assertio holdings inc-6,206,000
eyenovia inc-9,106,240
rekor systems inc-13,986,000
gossamer bio inc-3,792,350
draganfly inc.-1,989,920
aquestive therapeutics inc-7,926,480
geron corp-6,954,560
esperion therapeutics inc ne-9,568,000

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 54.9% of it's holdings in Healthcare sector.

Sector%
Healthcare54.9
Others17.6
Consumer Cyclical9.2
Consumer Defensive8.3
Technology6.6

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 29.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP31
LARGE-CAP25.5
UNALLOCATED17.5
SMALL-CAP16.4
MICRO-CAP4.5
MEGA-CAP4.1

Stocks belong to which Index?

About 0% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others100
Top 5 Winners (%)%
MMYT
makemytrip limited mauritius
OTLK
outlook therapeutics inc
2676.7 %
MBRX
moleculin biotech inc
974.5 %
BIAF
bioaffinity technologies inc
790.0 %
NXL
nexalin technology inc
375.0 %
Top 5 Winners ($)$
SWAV
shockwave med inc
30.9 M
MGNX
macrogenics inc
24.9 M
AGIO
agios pharmaceuticals inc
23.0 M
SUPN
supernus pharmaceuticals inc
18.2 M
KURA
kura oncology inc
15.3 M
Top 5 Losers (%)%
KTTA
pasithea therapeutics corp
-96.6 %
ACON
aclarion inc
-94.5 %
WKSP
worksport ltd
-60.8 %
COEP
coeptis therapeutics hldgs i
-57.7 %
MOTS
motus gi hldgs inc
-54.7 %
Top 5 Losers ($)$
NVRO
nevro corp
-23.3 M
IMVT
immunovant inc
-16.4 M
IRWD
ironwood pharmaceuticals inc
-14.4 M
CYTK
cytokinetics inc
-10.4 M
TVTX
travere therapeutics inc
-9.5 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 333 stocks in it's portfolio. About 14.7% of the portfolio is in top 10 stocks. NVRO proved to be the most loss making stock for the portfolio. SWAV was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions